In pharmaceutical modelling, cellular automata have been used as an established tool to represent molecular changes through discrete structural interactions. The data quality provided by such modelling is found suitable for the early drug design phase where flexibility is paramount. While both synchronous (CA) and asynchronous (ACA) types of automata have been used, analysis of their nature and...